US 11884740
Anti-CD20 antibody compositions
granted A61KA61K39/3955A61P
Quick answer
US patent 11884740 (Anti-CD20 antibody compositions) held by TG Therapeutics, Inc. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TG Therapeutics, Inc.
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K39/3955, A61P, A61P37/00